Teva discontinues study for chronic headache treatment

June 15 (Reuters) - Teva Pharmaceutical Inc said on Friday it would discontinue a trial testing its drug for the treatment of chronic cluster headache, after an analysis revealed that the drug was unlikely to meet the main goal of the study.